Skip to main content
. 2019 May 12;10(9):2006–2017. doi: 10.7150/jca.29807

Table 3.

Prognostic factors and treatment response in DLBCL patients in test cohort treated with CHOP or CHOP-like regimen.

Prognostic factors ORR,% P
EZH2 expression, high vs. low 34 vs. 67 0.042
Age >60 vs. ≤60 10 vs. 56 0.013
LDH, elevated vs. normal 17 vs. 100 0.000
Ann-Arbor stage, Ⅲ-Ⅳ vs.Ⅰ-Ⅱ 22 vs. 71 0.001
Extranodal sites, ≥2 vs. <2 9 vs. 58 0.006
IPI, 3-5 vs. 0-2 6 vs. 68 0.000
B symptom, yes vs. no 20 vs. 79 0.000